| Dr Thomas Cameron Brimer, MD | |
|
1948 Al Highway 157 Ste 450, Cullman, AL 35058-0643 | |
| (256) 735-5075 | |
| (256) 735-5076 |
| Full Name | Dr Thomas Cameron Brimer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 3 Years |
| Location | 1948 Al Highway 157 Ste 450, Cullman, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467957993 | NPI | - | NPPES |
| 272044 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 42702 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cullman Regional Medical Center | Cullman, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crmc Medical Group Llc | 8729419874 | 62 |
News Archive
AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.
Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Entity Name | Stopwatch Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841506458 PECOS PAC ID: 7719166230 Enrollment ID: O20110128000664 |
News Archive
AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.
Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Entity Name | Cullman Regional Medical Group Hospitalists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023642568 PECOS PAC ID: 5395176481 Enrollment ID: O20200505000860 |
News Archive
AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.
Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Entity Name | Crmc Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467083675 PECOS PAC ID: 8729419874 Enrollment ID: O20200506000409 |
News Archive
AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.
Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Cameron Brimer, MD Po Box 2895, Cullman, AL 35056-2895 Ph: (256) 735-5075 | Dr Thomas Cameron Brimer, MD 1948 Al Highway 157 Ste 450, Cullman, AL 35058-0643 Ph: (256) 735-5075 |
News Archive
AMHN, Inc., parent company of America's Minority Health Network, Inc. ("America's Minority Health Network"), announced today that its company information is now available via Standard & Poor's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of Standard & Poor's Advisor Insight.
Biota Holdings Limited advises that the Office of Biomedical Advanced Research and Development Authority within the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services has awarded up to an estimated US$231 million contract to its wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of laninamivir.
Cardiovascular Systems, Inc. (CSI), has received Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to evaluate the safety and effectiveness of its Diamondback 360® System in the treatment of calcified coronary lesions. With this conditional approval, CSI is authorized to begin its pivotal trial, ORBIT II, in early 2010 and initially enroll up to 100 patients at as many as 50 U.S. sites.
In support of Breast Cancer Awareness Month, Lady Foot Locker reaches out to women of all ages with a collection of fashionable "pink" products. Touting messages of hope and inspiration, the line supports the efforts of the American Cancer Society (ACS).
Current hospital cleaning protocol may be inadequate to rid patient rooms of multidrug-resistant (MDR) Acinetobacter baumannii, according to a study in the December issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 3 days ago
Joel T Johns, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2035 Al Highway 157, Cullman, AL 35058 Phone: 256-887-4996 Fax: 877-803-2404 | |
James Shu-lei Lee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2095 Fax: 256-737-2097 | |
Aesha Singh, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1930 Al Highway 157, Cullman, AL 35058 Phone: 256-735-5380 Fax: 256-417-4593 | |
Edward F. Mahan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2095 Fax: 256-737-2097 | |
Melinda Hart, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1890 Al Highway 157, Suite 300, Cullman, AL 35058 Phone: 256-737-8000 Fax: 256-737-8058 | |
Thomas B Oliver, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Main Ave Sw, Suite A, Cullman, AL 35055 Phone: 256-737-0880 | |
Dr. James R Matter, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 117 2nd Ave Se, Cullman, AL 35055 Phone: 256-739-4144 Fax: 256-739-0445 |